SEC Company Response from ChronoScale Holdings Corp (CHRN) (CIK 0001549084) (CHRN) — Jul 7, 2015
ChronoScale Holdings Corp (CHRN) (CIK 0001549084)
Date: July 7, 2015 · CIK: 0001549084 · Accession: 0001144204-15-041392
AI Filing Summary & Sentiment
File numbers found in text: 333-201168, 333-205168
Letter
Ekso Bionics Holdings, Inc.
1414 Harbour Way South,
Suite 1201
Richmond, CA 94804
July 7, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington D.C. 20549
Attention: Pamela A. Long
Edward M. Kelly
Re: Ekso Bionics Holdings, Inc.
Registration Statement on Form S-3
Filed June 25, 2015
File No. 333-205168
Ladies and Gentlemen:
Ekso Bionics Holdings, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3, File No. 333-201168, as amended, to 4:45 p.m., Eastern Time, on Thursday, July 9, 2015, or as soon thereafter as practicable.
The Company hereby acknowledges its responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the above-referenced Registration Statement. In connection with the foregoing request for acceleration of effectiveness, the Company hereby further acknowledges that:
· should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments or the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact Michelle L. Basil of Nutter McClennen & Fish LLP, counsel to the Company, at (617) 439-2477, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
Sincerely,
By:
/s/ Nathan Harding
Show Raw Text
CORRESP
1
filename1.htm
Ekso Bionics Holdings,
Inc.
1414 Harbour Way South,
Suite 1201
Richmond, CA 94804
July 7, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington D.C. 20549
Attention:
Pamela A. Long
Edward M. Kelly
Re:
Ekso Bionics Holdings, Inc.
Registration Statement on Form S-3
Filed June 25, 2015
File No. 333-205168
Ladies and Gentlemen:
Ekso Bionics Holdings, Inc. (the “Company”)
hereby requests acceleration of the effective date of its Registration Statement on Form S-3, File No. 333-201168, as amended,
to 4:45 p.m., Eastern Time, on Thursday, July 9, 2015, or as soon thereafter as practicable.
The Company hereby acknowledges its responsibilities
under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed
public offering of the securities specified in the above-referenced Registration Statement. In connection with the foregoing request
for acceleration of effectiveness, the Company hereby further acknowledges that:
· should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments or the declaration of effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.
Please contact Michelle L. Basil of Nutter
McClennen & Fish LLP, counsel to the Company, at (617) 439-2477, as soon as the Registration Statement has been declared effective,
or if you have any other questions or concerns regarding this matter.
Sincerely,
By:
/s/ Nathan Harding
Name:
Nathan Harding
Title:
Chief Executive Officer
2